Author:
Artham Surya M.,Lavie Carl J.,De Schutter Alban,Ventura Hector O.,Milani Richard V.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference85 articles.
1. Poirier P, Giles TD, Bray GA, et alObesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898–918.
2. •• Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925–1932. This details the impact of obesity on CHD, HF, HTN, and other CVDs, and the phenomenon called the “obesity paradox” and the weight reduction status.
3. Flegal KM, Carroll MD, Ogden CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002, 288:1723–1727.
4. Lavie CJ, Milani RV. Obesity and cardiovascular disease: the Hippocrates paradox? J Am Coll Cardiol 2003, 42:677–679.
5. American Obesity Association. AOA Fact Sheets: Obesity in the U.S.Washington, DC: American Obesity Association; 2002. Available at: http://www.obesity.org/subs/fastfacts/obesity_US.shtml . Accessed October 2010
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献